As pharmacy leaders balance daily clinical demands with long-term innovation, staying informed on emerging therapies and innovations is more critical than ever. Pharmacogenomics, biosimilars, and cell and gene therapies are advancing rapidly—and their clinical, financial, and operational implications are being felt across IDNs. These innovative topics are not only transforming treatment pathways, but also challenging formulary decisions, infrastructure readiness, and care delivery models.

Join industry thought leaders as they provide an update on some of the most influential topics in pharmacy today and outline actionable strategies for implementing or optimizing your organization’s current processes.

Learning Objectives:
1. Specify how pharmacogenomic insights are being applied within clinical decision-making across your organization.
2. Compare recent market trends in biosimilars and their impact on formulary decisions.
3. Outline the current state of cell and gene therapy adoption and the operational requirements needed for implementation.
4. Analyze the implications of these evolving pharmacy topics on your pharmacy.